{"id":"W4242184364","doi":"10.1200/jco.2019.37.7_suppl.170","title":"Keynote-365 cohort b: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Docetaxel; Medicine; Enzalutamide; Abiraterone; Prostate cancer; Prednisone; Internal medicine; Pembrolizumab; Oncology; Cohort; Pneumonitis; Cancer; Lung; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009916453,0.0009774421,0.0008094778,0.0003137316,0.0005219971,0.0007847098,0.0007611035,0.0008654856,0.007079743],"category_scores_gemma":[0.0007562339,0.0003652202,0.001110452,0.0003779905,0.0004326183,0.000671458,0.0005240623,0.001908745,0.001310907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001704458,"about_ca_system_score_gemma":0.002632143,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004638916,"about_ca_topic_score_gemma":0.006370744,"domain_scores_codex":[0.999676,0.0001003302,0.00003098417,0.00007624217,0.00003453331,0.000081903],"domain_scores_gemma":[0.9993242,0.00004805264,0.0001183855,0.00006850937,0.00005292923,0.0003879355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8023732,0.04332498,0.02957195,0.0008526612,0.001652521,0.0005132299,0.0003409318,0.002157839,0.01751357,0.0003288816,0.01640519,0.08496501],"study_design_scores_gemma":[0.4897445,0.4227119,0.05859636,0.0001603041,0.001070907,0.001081173,0.0002169021,0.0008692835,0.005065849,0.000315529,0.02011449,0.00005268254],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787892,0.002440852,0.0004920095,0.0004592907,0.0001394927,0.00481843,0.009692216,0.00006931584,0.003099129],"genre_scores_gemma":[0.9710484,0.001714731,0.001721853,0.001458911,0.0002420832,0.003944369,0.01522768,0.00002727386,0.004614793],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007079743,"threshold_uncertainty_score":0.02368414,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08204740760807967,"score_gpt":0.4387079840903892,"score_spread":0.3566605764823096,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}